//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile









Loading...
📢 New preprint alert ! www.biorxiv.org/content/10.6... Joanna Dembska developed a highly scalable image-base screening platform for protein turnover modulators in human neurons, based on our fluorescent timer system. Protein turnover is perturbed in nearly all neurodegenerative diseases ...
Postdoc position available now in the Smith Group lsi.exeter.ac.uk/groups/smith... to test the hypothesis that differentiation biases between human pluripotent stem cell lines may be eliminated by reversion to the naïve state. careers.exeter.ac.uk/vacancies/79...
1mo
3d
Not only at MIT...
Understanding pluripotency
lsi.exeter.ac.uk
www.biorxiv.org
Smith Group - Living Systems Institute - University of Exeter
8d
How do these compounds act ? Despite the fact that their known cellular targets are all different from each other, we found that all three compounds converged on inducing an increase in ribosomal protein expression, suggesting that enhancing protein synthesis may in turn stimulate protein turnover.
David Suter
Austin Smith
human models of alpha-synuclein mediated protein aggregation (model of Parkinson's disease). All 3 compounds were able to strongly reduce the formation of pathological fibrils in mouse neurons, and one was also potent in human ES cell-derived dopaminergic neurons...
and is involved in the formation of toxic aggregates. Joanna screened for nearly 6000 compounds, and found nearly 200 compounds increasing turnover in human neurons. After narrowing down the list, she focused on three compounds that were further tested by Anne-Laure Mahul-Mellier in mouse and...
Big 🙏 to everyone involved, first to fantastic Joanna Dembska who put so much hard work into this project, to AL Mahul-Mellier for the beautiful work on the PD disease models, and to the EPFL bioimaging, proteomics, genomics, & biomolecular screening facilities.
Help please! We need to do some large(ish) cell culture inhibiting E-cadherin with a monoclonal antibody. Does anyone have the DECMA-1 hybridoma cell line so we could purify our own antibody? or a similar monoclonal that would do the job. Any help greatly appreciated, just DM me. Please repost!
1mo